NATICK, Mass., May 15 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Piper Jaffray PCR Post-Op Summit in London.

Jim Tobin, President and Chief Executive Officer, will participate in a 40-minute question and answer session on Friday, May 22, beginning at approximately 9:30 a.m. London time.

A live webcast of Mr. Tobin's remarks will be available to all interested parties at Boston Scientific's website at www.bostonscientific.com Please visit for details on how to access the webcast. To ensure a timely connection to the webcast, it is recommended that users register at least 15 minutes before the webcast begins.

This webcast is being hosted by Piper Jaffray. The replay will be archived and available in the Investor Relations site at www.bostonscientific.com on May 22 at approximately one hour after the conclusion of the session.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com

    CONTACT:  Paul Donovan
              508-650-8541 (office)
              508-667-5165 (mobile)
              Media Relations
              Boston Scientific Corporation

              Larry Neumann
              508-650-8696 (office)
              Investor Relations
              Boston Scientific Corporation

SOURCE: Boston Scientific Corporation

Web site: http://www.bostonscientific.com/